Continuous Glucose Monitoring (CGM)
Customize your policy alerts
Sign up for all Moda Health policy alerts
Know when Moda Health releases new policies or updates existing guidance.
Monitor payer policy activity
Defines Moda Health coverage, prior authorization information, and clinical criteria for short-term diagnostic and long-term therapeutic use of FDA‑approved continuous glucose monitoring systems for members with diabetes.
Added requirements for implantable CGM and its continued usage and removed age limits.
Updated CGM description and grammar for long-term therapeutic use; removed age limits.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.